Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Source filing unavailable
Q4 2015 · —
Revenue$4.65B$4.65B+3.6% vs Q4 2014 Net income—
EPS Diluted$1.50$1.50+0.7% vs Q4 2014 Gross Profit$2,108,300,000+0.8% Operating Incomederived$690,000,000+8.0% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$1,223,700,000+53.5% Margins · derivedGross margin45.3%−1.2 pt vs Q4 2014
Operating margin14.8%+0.6 pt vs Q4 2014